Navigation Links
BioMS Medical reports Spectral receives FDA approval to initiate pivotal trial and closes financing for $19.5 million
Date:3/3/2010

more than 70,000 patients globally and has demonstrated in clinical trials that it safely and effectively removes endotoxin and reduces mortality in patients with severe sepsis. There are over 250,000 patients who develop severe sepsis in the US each year and who currently face a high risk of mortality with limited treatment options, representing a potential market opportunity in excess of $1 billion per annum.

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the investment, development and commercialization of pharmaceutical technologies. For further information please visit our website at http://www.biomsmedical.com

This press release may contain forward-looking statements, which reflect the Corporation's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market condition
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis
2. BioMS Medical provides corporate update
3. BioMS Medical Announces Third Quarter 2009 Results
4. BioMS Medical announces second quarter 2009 results
5. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
6. BioMS Medical to participate in panel session at Bio International Convention 2009
7. BioMS Medical Announces First quarter 2009 results
8. BioMS Medical to present at Alberta Economic Forum in Geneva
9. BioMS Medical to present at BioFinance 2009
10. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
11. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... REYKJAVIK, Iceland , June 3, 2015   ... genome to improve health worldwide, today announced that it ... to provide clinical interpretation of the whole genome sequences ... of the first phase of the 100,000 Genomes Project ... WuXi NextCODE will deploy its unique database ...
(Date:6/3/2015)... 2015 Marktech Optoelectronics is pleased to ... APD’s have an internal gain mechanism, fast time response, ... infrared region. These APD’s are recommended for applications that ... to overcome high pre-amp noise. In addition, Marktech APD's ... ideal for extreme low-level light detection and short pulse ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 GEA's ... , which is a standalone, fully-equipped laboratory unit that ... for limited productions in pilot plants. The Panther™ NS3006L ... its compact design allows for easy installation with simple ... products. This homogenizer can be used in many different ...
(Date:6/3/2015)... June 03, 2015 From smart street ... important part in enabling success in dealing with important ... technology leaders helped bring focus to the role and ... Photonics21 annual meeting last week in Brussels. ... event, held 28 and 29 May at the Hotel ...
Breaking Biology Technology:WuXi NextCODE Wins Genomics England Clinical Interpretation Tender in both Rare Disease and Cancer 2Marktech Introduces New Line of APDs 2GEA Announces the Panther™ NS3006L, a Self-Contained, Fully-Equipped Laboratory Homogenizer Well Suited for Pilot Plants 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 3
... taskforce of forest industry,stakeholders from Eastern Canada ... bio-related opportunities within the forestry sector across ... is comprised of regional government,industry, federal and ... has come together to better understand what,opportunities ...
... the Ferring Research,Infertility and Gynaecology GrAnt (FRIGGA) are ... & Embryology Congress. The two,winners of this new ... and the Universitair Ziekenhuis (UZ) Brussel, Centre for,Reproductive ... for their outstanding,proposals for fundamental research to help ...
... 7 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: NTII ), ... officer (CEO), has announced his,intent to retire on December ... serve on the Board. Mr. Freiman is the former ... Mr. Freiman is retiring after 11 years of ...
Cached Biology Technology:Atlantica BioEnergy Task Force Unveiled 2Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2008 Winners Announced 2Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2008 Winners Announced 3Neurobiological Technologies' CEO to Retire on December 31, 2008 2
(Date:4/14/2015)... , April 14, 2015  HYPR Corp. ... Online (FIDO ® ) Alliance tm , an ... FIDO members commit to share technology and collaborate ... that are interoperable, more secure and private, and ... biometric identity verification that protects sensitive user information ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NEC Security Competitive Profile 2015 2
... for alternative ,medicines, and luxury goods in Asian markets, ... being invested in enforcement, while events such as China,s ... problem. However, research in Conservation Letters ... the ,War on Drugs, as they lack a long-term ...
... of Visualized Experiments , published a modern approach to ... intriguing research questions facing scientists todaythe origin of life ... is comprised of a modern and simplified approach to ... Harold Urey in 1953. Their research evaluated the possibility ...
... air pollution blowing across the Pacific Ocean is often caused ... and Europe, according to findings by UC Irvine and other ... Academy of Sciences . The study is the first ... is from the production in China of cellphones, televisions and ...
Cached Biology News:A 21st century adaptation of the Miller-Urey origin of life experiments 2Made in China for us: Air pollution tied to exports 2
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGF1α by GC- or LC-mass spectrometry....
...
Antibodies were affinity purified using epitopes specific to PPP1CC immobilized on solid support....
ANTI GELSOLIN...
Biology Products: